Background -Active oxygen species are thought to play a part in ischaemia reperfusion injury. The ability of a novel agent, human thioredoxin (hTRX), to attenuate lung damage has been examined in a rat model of ischaemia reperfusion injury.
Abstract
Background -Active oxygen species are thought to play a part in ischaemia reperfusion injury. The ability of a novel agent, human thioredoxin (hTRX), to attenuate lung damage has been examined in a rat model of ischaemia reperfusion injury.
Methods -Twenty eight animals were studied. At thoracotomy the left main bronchus and the left main pulmonary artery were clamped for 75 minutes and the lung was then reperfused for 20 minutes. Phosphate buffered saline was administered intravenously to nine control animals and hTRX (30 pg/g body weight)
was given intravenously to another group of nine animals. Two experiments were carried out. The first (Exp 1) was a time matched pair experiment (five treated, five controls), and the second (Exp 2) was performed under controlied conditions (four treated, four controls; temperature 25°C, humidity 65%). In another 10 nonischaemic rats and those in Exp 1 biochemical measurements of lipid peroxide, superoxide dismutase, and glutathione peroxide levels were performed. Results -In both experiments rats perfused with hTRX survived longer than controls. In Exp 1 the arterial oxygen tension (Pao2) on air in the hTRX group was higher at 20 minutes than at one minute after reperfusion. In Exp 2 Pao2 at 20 minutes was higher in the hTRX group than in the controls. Lipid peroxide, superoxide dismutase, and glutathione peroxide levels in the control group were higher than in the hTRX group and in the non-ischaemic groups. Histological examination showed less thickening and oedema of the alveolar walls in the hTRX group than in controls. Conclusions -These results suggest that hTRX is effective as a radical scavenger and can limit the extent of ischaemia reperfusion injury of the lungs of experimental animals. (Thorax 1995; 50:387-391) Keywords: human thioredoxin, ischaemia reperfusion injury, lung, radical scavenger.
Ischaemia reperfusion injury has been studed widely in many transplantation and ischaemia models of animal organs including the heart,' intestines,2 and kidney,3 and toxic oxygen metabolites have been shown to play a major part in this condition. In lung transplantation pulmonary capillary oedema occurs early after surgery and respiratory failure can occur; this is called "pulmonary reimplanting responses".'
These responses are considered to be due partly to disruption of nerves, lymphatic vessels, and bronchial vessels, as well as to ischaemic injury but, more importantly, to oxygen free radicals that are generated during reperfusion.
Human thioredoxin (hTRX) is a polypeptide consisting of 104 amino acids with a molecular weight of about 12 OOO.5 The active site of hTRX has the amino acid sequence -Cys-GlyPro-Cys-which participates in reduction reactions through reversible oxidation ofits active centre dithiol to a disulphide. Using this rat lung ischaemia reperfusion model we now present data which assess the protective effect of hTRX on ischaemia reperfusion injury of the lung.
Methods
Two kinds of experiments were designed. The first (Exp 1) was a time matched pair experiment in which treated and control animals were examined simultaneously. The second (Exp 2) was conducted under carefully controlled environmental conditions of temperature 25°C and humidity 65%.
Male Wistar rats (body weight 240-260 g) were anaesthetised by subcutaneous injection of atropine sulphate (0-01 mg) and intraperitoneal injection of pentobarbitone (25 mg/ kg) and pancuronium bromide (0-1 mg). The trachea was intubated with a 19 gauge intravenous cannula. In Exp 2 the trachea was ligated around the cannula so that air could not leak around the tube. Animals were mechanically ventilated with a Harvard pump using 100% oxygen, a tidal volume of 2 5 ml, a positive end expiratory pressure of 2 cm H2O, and a respiratory rate of 80 breaths/min. 24 gauge intravenous cannulae were inserted into the left carotid artery for sampling arterial blood and into the right femoral vein for the administration of phosphate buffered saline (PBS) or hTRX in PBS.
The sternum was cut transversely under a microscope (Zeiss Co Ltd, Oberkochen, Germany), extending to a bilateral thoracotomy at the fifth intercostal level, and the left pulmonary artery and left main bronchus were isolated. Heparin (0-1 ml) was injected into the left common carotid artery. The left pulmonary artery and the left main bronchus were clamped with microclips (Micro Clips, Edward Weck Co, Research Triangle Park, North Carolina, USA). In Exp 1 the bronchus was clamped at the end of expiration and in Exp 2 at the end of inspiration.
For Exp 1 the left lung was rendered ischaemic in the deflated state for 75 minutes. The clamps were then removed and the right pulmonary artery clamped. Operations were performed in matched pairs from the two groups (five hTRX treated rats, five controls). The same instruments were used and the entire procedure, including the operative manoeuvres, was carried out at an interval of 15 minutes in the treated and control animals. The room temperature was 25-27'C and the humidity 60-70%.
In Exp 2, after the clamps had been removed, the right hilum was totally clamped under carefully controlled environmental conditions of 25°C and 65% humidity.
hTRX in PBS was injected into the right femoral vein of the treated rats immediately before reperfusion (hTRX 10 ,ug/g, 0 5 ml) and continuously for two minutes starting one minute after reperfusion (hTRX 20 jig/g, 1 ml). In the controls PBS was injected into the right femoral vein immediately before reperfusion (0-5 ml) and for two minutes continuously starting one minute after reperfusion (1 ml).
Plasmids possessing the hTRX gene were transformed in E coli, multiplied by mass cultivation, and bacterial hTRX extracted.1' Recombinant hTRX was provided by Ajinomoto Company (Kawasaki, Japan).
The following measurements were also made:
Arterial blood gas analysis. Arterial blood (0-2 ml) was drawn from the carotid artery 1, 10, and 20 minutes after reperfusion and analysed with an automated blood gas analyser (ABL300, Radiometer Company, Copenhagen, Denmark).
Wetldry (WID) ratio of lung tissue. The lower third of the left lung was weighed 20 minutes after reperfusion or at death (wet weight), and after being dried at 70'C for three days (dry weight), and the W/D ratio was calculated.
Histological examination (Exp 1 only). The upper third of the left lung was immersed in formalin 20 minutes after reperfusion (or at death). Tissue sections were stained with haematoxylin and eosin.
Biochemical assays (Exp 1 only). The middle third of the left lung was frozen immediately at -20°C 20 minutes after reperfusion (or at death). For the preparation of tissue extracts 10 volumes of ice cold 0 1 mol Tris-Cl, pH 7 5, 2 mmol EDTA was added to one volume frozen tissue. After homogenisation and centrifugation at 16 000 rpm for three minutes supernatants were collected and aliquots were stored at -700C. Assay for lipid peroxides (thiobarbituric acid reactants).1" The sample was mixed and heated at 950C for 60 minutes and thiobarbituric acid reactants were extracted with n-butanol. The butanol phase was separated by centrifugation and the absorbance was measured at 532 and 553nm.
Glutathione peroxidase (GPx) assay. 4 The assay mixture (120 1l) contained 0 1 mol TrisCl, pH 7*5, 2 mmol EDTA, 0-2 mmol NADPH, 1 mmol sodium azide, 1 mmol reduced glutathione, 0-25 units/ml glutathione reductase (type IV from bakers yeast, Sigma Chemical Co, St Louis, Missouri, USA), and the sample. The reaction was started by the addition of H202 to 0-15mmol and the determination was based on the oxidation of NADPH at 340 nm at 250C.
Superoxide dismutase (SOD) assay. " SOD activity was determined by the cytochrome C reduction assay. The assay mixture (600 p1) contained 0-1 mol Tris-Cl, pH7*5, 2mmol EDTA, 0 05 mmol xanthine, 2 ,ug/ml xanthine oxidase, 6 1tmol cytochrome C, and the sample. The reduction of cytochrome C was monitored at 550 nm. One unit of SOD was defined as the amount of enzyme which inhibits the rate of cytochrome C reduction by 50%.
Two other groups (n =5) of rats without ischaemia were selected to examine the influence of hTRX on these biochemical values. These animals were injected with PBS or PBS with hTRX (30 gg/g) via the right femoral vein fig 2) the Pao2 in the hTRX group did not fall after reperfusion, but in the control group it fell significantly 20 minutes after reventilated for 20 minutes without any isch-perfusion. In the hTRX group the Pao2 was iia. The middle third of the left lung was significantly higher than in the control group mined as above. higher than in the hTRX group (27-7 (2 8) nmol/g) and the non-ischaemic groups. There was no difference between the two non-ischaemic groups.
The mean values of GPx and SOD activity in the control group were significantly higher than in the hTRX group (table; p<005). There was no difference between the two non-ischaemic groups.
Discussion
Oxygen free radicals and oxygen metabolites generated during reperfusion are known to be involved in reperfusion injury. Active oxygen is produced by xanthine oxidase, neutrophils, and alveolar macrophages; however, the precise source of oxygen free radicals in ischaemia reperfusion injury remains to be clarified. '6 Human thioredoxin contains the amino acid sequence -Cys-Gly-Pro-Cys-and closely resembles the thioredoxin of E coli. The rats perfused with hTRX survived longer than the controls in both experiments. In Exp 1 Pao2 fell significantly and improved only in the hTRX group. Oxygenation is thought to be the best index for the evaluation of lung function'8 and these results suggest that hTRX has a protective effect against ischaemia reperfusion injury of the lung.
A comparison of these two experiments shows that, in Exp 2, Pao2 in the hTRX group did not fall as it did in Exp 1. This may be because (1) the ischaemia reperfusion injury in Exp 2 was not as severe as in Exp 1 since the left lung was not deflated during ischaemia; and (2) after reperfusion arteriovenous shunts in Exp 2 were less than in Exp 1 because the right hilum was totally clamped in Exp 2 preventing a decrease in the tidal volume.
Hydroxyl radicals can initiate a chain reaction of lipid peroxidation in endothelial cell membranes. Lipid peroxides made thus contribute greatly to tissue damage, ultimately leading to altered permeability and oedema. '9 In this study lipid peroxide levels in the hTRX group were significantly lower than in the control group after reperfusion and the same in both the non-ischaemic groups, which suggests that hTRX may act as a radical scavenger and suppress lung oedema. Our histological examination supported this hypothesis. However, no significant difference was observed in the W/D ratios between the two groups. This may be because reperfusion injury is due, at least in part, to factors other than oxygen free radicals, or because there was insufficient time to develop pulmonary oedema in the control groups.
SOD is an effective radical scavenger which protects cells from oxidation by catalysing the dismutation of superoxide anion to H,02.1' GPx is a non-specific peroxide scavenger which catalyses the oxidation of glutathione.'9 In this study tissue concentrations ofboth these radical scavengers were significantly lower in the hTRX group. Furthermore, the values of SOD and GPx in the ischaemia reperfusion injury group were higher than those in the non-ischaemic groups. On the other hand, the Pao2 at 20 minutes in the hTRX group was significantly higher than in the control group, and lipid peroxides in the hTRX group were lower than in the control group. Although it is uncertain that enzymes of this type can be induced in such a short time, it is possible that the low SOD and GPx concentrations in the hTRX group were due to the inhibition of reperfusion injury by hTRX.
In summary, the administration of hTRX improved survival and oxygenation and inhibited the production of lipid peroxides generated by active oxygen species in this rat model of ischaemia reperfusion injury. These results suggest that human thioredoxin may be effective as a radical scavenger in the treatment of reperfusion injury of the lung.
